Financial performance highlights (QQ2 2025):
- Revenue: Not disclosed for QQ2 2025
- Operating loss: ($229,924)
- Net income: ($249,095)
- EBITDA: ($229,924)
- Interest expense: $19,171
- EPS: ($0.0047)
- Weighted average shares: 52,957,572
- R&D expenses: $82,087
- G&A expenses: $147,837
- Cash from operations: ($121,299)
- Net change in cash: ($162)
- Cash at end of period: $4,745
Balance sheet and liquidity:
- Total assets: $104,745
- Total liabilities: $16,109,037
- Short-term debt: $6,733,979
- Cash and equivalents: $4,745
- Intangible assets: $100,000
- Retained earnings: ($78,168,292)
- Total stockholders' equity: ($16,004,292)
- Net debt: $6,729,234
- Current ratio: 0.0003; Quick ratio: 0.0003; Cash ratio: 0.0003
- Revenue visibility: Not disclosed for QQ2 2025; last reported quarterly revenue figures are inconsistent in the provided data
- Valuation signals: Enterprise value multiple: β29.38; Price/book and related multiples negative due to negative equity
Notes on YoY/QoQ metrics (from earnings metrics):
- Operating income YoY: +59.15%; QoQ: +16.71% (still negative at ($229,924))
- Net income YoY: β120.80%; QoQ: +15.45%
- EPS YoY: β118.80%; QoQ: +16.07%